HyQvia▼ (human normal immunoglobulin and recombinant human hyaluronidase): crimping defect in hyaluronidase vial

Small number of HY vials could potentially be impacted; the defect is not associated with the immunoglobulin vial, and there is not thought to be an impact on the product's usability, safety, and quality, thus no action is required.

Source:

Baxalta Innovations GmbH